Trials / Completed
CompletedNCT00398541
Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)
Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the antihypertensive and neuroprotective effects of Hyzaar(R) in elderly subjects in comparison with Natrilix(TM).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | losartan potassium (+) hydrochlorothiazide | losartan potassium (+) hydrochlorothiazide combination will be titrated upwards according to the following scheme: losartan potassium 50/hydrochlorothiazide 12.5 then losartan potassium 100/hydrochlorothiazide 12.5 then losartan potassium 100/hydrochlorothiazide 25 |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2007-04-10
- Completion
- 2007-06-01
- First posted
- 2006-11-10
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00398541. Inclusion in this directory is not an endorsement.